4baseCare

“4baseCare secured $13.4M in Series B funding. This capital fuels global genomics lab expansion and scales OncoTwin, its AI platform.”

“This capital fuels global genomics lab expansion and scales OncoTwin, its AI platform. The company targets diverse populations, decentralizing cancer diagnostics.”

“India is not just a services economy anymore — it is producing unicorns in sovereign AI, residential solar, precision manufacturing, and precision oncology simultaneously, with global investors leading the rounds.”

“Cell therapy and precision oncology are moving from bespoke, manual processes to industrialized, automated production — a critical bottleneck breakthrough that could unlock mass patient access to next-generation treatments.”